Proteomics

Dataset Information

0

Targeting kinome reprogramming in ESR1 fusion-driven breast cancer


ABSTRACT: Multiplexed, deep-scale LC-MSMS analysis for proteome and phosphoproteome expression profile and the targeted LC-MSMS analysis for kinases in enriched kinome of the ER+ breast cancer patient-derived xenograft tumors.

INSTRUMENT(S): LTQ Orbitrap

ORGANISM(S): Homo Sapiens (human) Mus Musculus (mouse)

TISSUE(S): Breast

DISEASE(S): Breast Cancer

SUBMITTER: Meggie Young  

LAB HEAD: Charles E. Foulds

PROVIDER: PXD036644 | Pride | 2023-10-24

REPOSITORIES: Pride

altmetric image

Publications


Transcriptionally active ESR1 fusions (ESR1-TAF) are a potent cause of breast cancer endocrine therapy (ET) resistance. ESR1-TAFs are not directly druggable because the C-terminal estrogen/anti-estrogen-binding domain is replaced with translocated in-frame partner gene sequences that confer constitutive transactivation. To discover alternative treatments, a mass spectrometry (MS)-based kinase inhibitor pulldown assay (KIPA) was deployed to identify druggable kinases that are upregulated by diver  ...[more]

Similar Datasets

2012-08-10 | E-GEOD-39982 | biostudies-arrayexpress
2020-09-28 | PXD019585 | Pride
2009-06-29 | E-GEOD-13299 | biostudies-arrayexpress
2012-05-02 | E-GEOD-36892 | biostudies-arrayexpress
2015-04-10 | E-GEOD-60752 | biostudies-arrayexpress
2018-05-01 | E-MTAB-6204 | biostudies-arrayexpress
2015-06-04 | E-GEOD-67387 | biostudies-arrayexpress
2013-11-07 | E-GEOD-52126 | biostudies-arrayexpress
2024-10-28 | PXD052835 | Pride
2016-12-24 | PXD004820 | Pride